Spreading the word of hope with Lakewood BlueClaws radio
Related News
A Potential Disease-Modifying Therapy Being Developed for Duchenne Muscular Dystrophy
Catabasis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, today...
Reaching the Finish Line for Duchenne Muscular Dystrophy: An Update on the Grand to Grand Ultra
The surroundings were familiar, and the terrain—similar, but more intense than...
A Father Races to Save His Son
Jim Raffone takes on endurance events to fight a rare disease...
Rare Disease Report
James Raffone, Founder and CEO of JAR of Hope is using muscle-dependent activities...
JAR of Hope Rings the New York Stock Exchange Closing Bell
Officials and guests of JAR of Hope visit the NYSE. JAR of Hope’s mission...